Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma × Gels × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 10 Condylomata Acuminata 3 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Warts 1 Virus Diseases 1 Usual Type Vulval Intraepithelial Neoplasia (uVIN) 1 Urologic Neoplasms 1 Urologic Diseases 1 Urinary Bladder Neoplasms 1 Urinary Bladder Diseases 1 Sexually Transmitted Diseases 1 Radiodermatitis 1 Papillomavirus Infections 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Keratosis, Seborrheic 1 Hemangioma, Cavernous 1 Hemangioma 1 Head and Neck Cancer Patients Treated With Radiotherapy 1 Exanthema 1 Dermatitis, Contact 1 Carcinoma, Basal Cell 1 Carcinoma 1

Interventions

Carboplatin 26 Paclitaxel 22 Cisplatin 21 Gemcitabine 17 pembrolizumab 12 Fluorouracil 9 Pemetrexed 8 Everolimus 8 Docetaxel 8 Cetuximab 8 Radiotherapy, Intensity-Modulated 7 Radiotherapy 7 130-nm albumin-bound paclitaxel 7 Sorafenib 6 Nivolumab 6 Axitinib 6 epothilone B 5 Sunitinib 5 Panitumumab 5 Cyclophosphamide 5 Bevacizumab 5 trebananib 4 reolysin 4 padeliporfin 4 lenvatinib 4 Radiation 4 Irinotecan 4 Gefitinib 4 vosaroxin 3 volociximab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03546166 2023-07-21

PICABAS

Centre Hospitalier Universitaire de Nice

Phase 2 Completed

Carcinoma, Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡